Cardiovascular Systems Inc 4
4 · Cardiovascular Systems Inc · Filed Aug 25, 2014
Insider Transaction Report
Form 4
Thatcher Robert J
Executive VP
Transactions
- Sale
Common Stock
2014-08-21$28.52/sh−1,263$36,019→ 104,733 total - Sale
Common Stock
2014-08-21$29.36/sh−791$23,223→ 103,942 total - Sale
Common Stock
2014-08-22$29.45/sh−1,171$34,484→ 102,771 total
Holdings
- 265
Stock Option (right to buy)
Exercise: $8.83Exp: 2017-04-17→ Common Stock (265 underlying) - 64,700
Stock Option (right to buy)
Exercise: $12.37Exp: 2015-10-16→ Common Stock (64,700 underlying) - 32,350
Stock Option (right to buy)
Exercise: $12.15Exp: 2017-12-11→ Common Stock (32,350 underlying)
Footnotes (5)
- [F1]In connection with the vesting and delivery of restricted stock and pursuant to a Rule 10b5-1 trading plan, on the date the shares were sold the net proceeds were used to pay required withholding taxes.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.03 to $29.02 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.03 to $29.63 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.29 to $29.55 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]Fully exercisable.